{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:56:24Z","timestamp":1793048184810,"version":"4.5.0"},"reference-count":31,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1304303"],"award-info":[{"award-number":["2016YFC1304303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Currently, there are no reliable diagnostic and prognostic markers for\nMalignant Pleural Mesothelioma (MPM). The objective of this study was to identify hub genes that\ncould be helpful for diagnosis and prognosis in MPM by using bioinformatics analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>The gene expression profiles were downloaded from the Gene Expression\nOmnibus (GEO) database and The Cancer Genome Atlas (TCGA). Weighted Gene Co-expression\nNetwork Analysis (WGCNA), LASSO regression analysis, Cox regression analysis, and Gene Set\nEnrichment Analysis (GSEA) were performed to identify hub genes and their functions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 430 upregulated and 867 downregulated genes in MPM were identified based\non the GSE51024 dataset. According to the WGCNA analysis, differentially expressed genes were\nclassified into 8 modules. Among them, the pink module was most closely associated with MPM.\nAccording to genes with GS &gt; 0.8 and MM &gt; 0.8, six genes were selected as candidate hub genes\n(NUSAP1, TOP2A, PLOD2, BUB1B, UHRF1, KIAA0101) in the pink module. In the LASSO\nmodel, three genes (NUSAP1, PLOD2, and KIAA0101) were identified with non-zero regression\ncoefficients and were considered as hub genes among the 6 candidates. The hub gene-based\nLASSO model can accurately distinguish MPM from controls (AUC=0.98). Moreover, the high\nexpression level of KIAA0101, PLOD2, and NUSAP1 was associated with poor prognosis\ncompared to the low level in Kaplan\u2013Meier survival analyses. After further multivariate Cox\nanalysis, only KIAA0101 (HR = 1.55, 95% CI = 1.05-2.29) was identified as an independent\nprognostic factor among these hub genes. Finally, GSEA revealed that high expression of\nKIAA0101 was closely associated with 10 signaling pathways.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our study identified several hub genes relevant to MPM, including NUSAP1,\nPLOD2, and KIAA0101. Among these genes, KIAA0101 appears to be a useful diagnostic and\nprognostic biomarker for MPM, which may provide new clues for MPM diagnosis and therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207324666210707105634","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T03:53:06Z","timestamp":1625802786000},"page":"1498-1506","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic\nand Prognostic Marker"],"prefix":"10.2174","volume":"25","author":[{"given":"Zongan","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital,\nSichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital,\nSichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuean","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital,\nSichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital,\nSichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"Bibby A.C.","year":"2016","unstructured":"Bibby A.C.; Tsim S.; Kanellakis N.; Ball H.; Talbot D.C.; Blyth K.G.; Maskell N.A.; Psallidas I.; Malignant pleural mesothelioma: An update on investigation, diagnosis and treatment. Eur Respir Rev 2016,25(142),472-486","journal-title":"Eur Respir Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.6004\/jnccn.2012.0006","volume":"10","author":"Ettinger D.S.","year":"2012","unstructured":"Ettinger D.S.; Akerley W.; Borghaei H.; Chang A.; Cheney R.T.; Chirieac L.R.; D\u2019Amico T.A.; Demmy T.L.; Ganti A.K.; Govindan R.; Grannis F.W.; Horn L.; Jahan T.M.; Jahanzeb M.; Kessinger A.; Komaki R.; Kong F.M.; Kris M.G.; Krug L.M.; Lennes I.T.; Loo B.W.; Martins R.; O\u2019Malley J.; Osarogiagbon R.U.; Otterson G.A.; Patel J.D.; Schenck M.P.; Pisters K.M.; Reckamp K.; Riely G.J.; Rohren E.; Swanson S.J.; Wood D.E.; Yang S.C.; Malignant pleural mesothelioma. J Natl Compr Canc Netw 2012,10(1),26-41","journal-title":"J Natl Compr Canc Netw"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jfma.2018.07.013","volume":"118","author":"Lin R-T.","year":"2019","unstructured":"Lin R-T.; Chang Y-Y.; Wang J-D.; Lee L.J-H.; Upcoming epidemic of asbestos-related malignant pleural mesothelioma in taiwan: A prediction of incidence in the next 30 years. J Formos Med Assoc 2019,118(1 Pt 3),463-470","journal-title":"J Formos Med Assoc"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","volume":"88","author":"Beckett P.","year":"2015","unstructured":"Beckett P.; Edwards J.; Fennell D.; Hubbard R.; Woolhouse I.; Peake M.D.; Demographics, management and survival of patients with malignant pleural mesothelioma in the national lung cancer audit in england and Wales. Lung Cancer 2015,88(3),344-348","journal-title":"Lung Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"Zalcman G.","year":"2016","unstructured":"Zalcman G.; Mazieres J.; Margery J.; Greillier L.; Audigier-Valette C.; Moro-Sibilot D.; Molinier O.; Corre R.; Monnet I.; Gounant V.; Rivi\u00e8re F.; Janicot H.; Gervais R.; Locher C.; Milleron B.; Tran Q.; Lebitasy M.P.; Morin F.; Creveuil C.; Parienti J.J.; Scherpereel A.; Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): A randomised, controlled, open-label, phase 3 trial. Lancet 2016,387(10026),1405-1414","journal-title":"Lancet"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S1470-2045(18)30100-1","volume":"19","author":"Scherpereel A.","year":"2018","unstructured":"Scherpereel A.; Wallyn F.; Albelda S.M.; Munck C.; Novel therapies for malignant pleural mesothelioma. Lancet Oncol 2018,19(3),e161-e172","journal-title":"Lancet Oncol"},{"key":"ref=7","first-page":"63","volume":"7","author":"Patel S.C.","year":"2016","unstructured":"Patel S.C.; Dowell J.E.; Modern management of malignant pleural mesothelioma. Lung Cancer (Auckl) 2016,7,63-72","journal-title":"Lung Cancer (Auckl)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","volume":"6","author":"Henry N.L.","year":"2012","unstructured":"Henry N.L.; Hayes D.F.; Cancer biomarkers. Mol Oncol 2012,6(2),140-146","journal-title":"Mol Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"ii33","DOI":"10.1093\/jac\/dkq523","volume":"66","author":"Kibe S.","year":"2011","unstructured":"Kibe S.; Adams K.; Barlow G.; Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 2011,66(Suppl. 2),ii33-ii40","journal-title":"J Antimicrob Chemother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.copbio.2007.11.005","volume":"19","author":"Werner T.","year":"2008","unstructured":"Werner T.; Bioinformatics applications for pathway analysis of microarray data. Curr Opin Biotechnol 2008,19(1),50-54","journal-title":"Curr Opin Biotechnol"},{"key":"ref=11","first-page":"838","volume":"22","author":"Tao Z.","year":"2017","unstructured":"Tao Z.; Shi A.; Li R.; Wang Y.; Wang X.; Zhao J.; Microarray bioinformatics in cancer- a review. J BUON 2017,22(4),838-843","journal-title":"J BUON"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Weinstein J.N.","year":"2013","unstructured":"Weinstein J.N.; Collisson E.A.; Mills G.B.; Shaw K.R.M.; Ozenberger B.A.; Ellrott K.; Shmulevich I.; Sander C.; Stuart J.M.; The cancer genome atlas pan-cancer analysis project. Nat Genet 2013,45(10),1113-1120","journal-title":"Nat Genet"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","author":"Clough E.","year":"2016","unstructured":"Clough E.; Barrett T.; The gene expression omnibus\ndatabase. Statistical genomics Springer2016,93-110","journal-title":"Statistical genomics"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"Langfelder P.","year":"2008","unstructured":"Langfelder P.; Horvath S.; WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 2008,9,559","journal-title":"BMC Bioinformatics"},{"key":"ref=15","first-page":"1","volume":"30","author":"Fonti V.","year":"2017","unstructured":"Fonti V.; Belitser E.; Feature selection using lasso. VU\nAmsterdam Research Paper in Business Analytics 2017,30,1-25","journal-title":"VU\nAmsterdam Research Paper in Business Analytics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G.","year":"2012","unstructured":"Yu G.; Wang L-G.; Han Y.; He Q-Y.; clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 2012,16(5),284-287","journal-title":"OMICS"},{"key":"ref=17","first-page":"135","author":"Pei G.","year":"2017","unstructured":"Pei G.; Chen L.; Zhang W.;  WGCNA application to proteomic and metabolomic data analysisMethods in enzymology 2017,135-158","journal-title":"WGCNA application to proteomic and metabolomic data analysisMethods in enzymology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"Sing T.","year":"2005","unstructured":"Sing T.; Sander O.; Beerenwinkel N.; Lengauer T.; ROCR: Visualizing classifier performance in R. Bioinformatics 2005,21(20),3940-3941","journal-title":"Bioinformatics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"Subramanian A.","year":"2005","unstructured":"Subramanian A.; Tamayo P.; Mootha V.K.; Mukherjee S.; Ebert B.L.; Gillette M.A.; Paulovich A.; Pomeroy S.L.; Golub T.R.; Lander E.S.; Mesirov J.P.; Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005,102(43),15545-15550","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","volume":"41","author":"Remon J.","year":"2015","unstructured":"Remon J.; Reguart N.; Corral J.; Lianes P.; Malignant pleural mesothelioma: New hope in the horizon with novel therapeutic strategies. Cancer Treat Rev 2015,41(1),27-34","journal-title":"Cancer Treat Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1038\/sj.onc.1209320","volume":"25","author":"Warbrick E.","year":"2006","unstructured":"Warbrick E.; A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design. Oncogene 2006,25(20),2850-2859","journal-title":"Oncogene"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1073\/pnas.1106136108","volume":"108","author":"Emanuele M.J.","year":"2011","unstructured":"Emanuele M.J.; Ciccia A.; Elia A.E.H.; Elledge S.J.; Proliferating cell nuclear antigen (PCNA)-associated KIAA0101\/PAF15 protein is a cell cycle-regulated anaphase-promoting complex\/cyclosome substrate. Proc Natl Acad Sci USA 2011,108(24),9845-9850","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexcr.2005.09.020","volume":"312","author":"Simpson F.","year":"2006","unstructured":"Simpson F.; Lammerts van Bueren K.; Butterfield N.; Bennetts J.S.; Bowles J.; Adolphe C.; Simms L.A.; Young J.; Walsh M.D.; Leggett B.; Fowles L.F.; Wicking C.; The PCNA-associated factor KIAA0101\/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res 2006,312(1),73-85","journal-title":"Exp Cell Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"e26866","DOI":"10.1371\/journal.pone.0026866","volume":"6","author":"Jain M.","year":"2011","unstructured":"Jain M.; Zhang L.; Patterson E.E.; Kebebew E.; KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS One 2011,6(11),e26866","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lungcan.2011.05.024","volume":"75","author":"Kato T.","year":"2012","unstructured":"Kato T.; Daigo Y.; Aragaki M.; Ishikawa K.; Sato M.; Kaji M.; Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer 2012,75(1),110-118","journal-title":"Lung Cancer"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/labinvest.2013.124","volume":"93","author":"Cheng Y.","year":"2013","unstructured":"Cheng Y.; Li K.; Diao D.; Zhu K.; Shi L.; Zhang H.; Yuan D.; Guo Q.; Wu X.; Liu D.; Dang C.; Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Lab Invest 2013,93(12),1276-1287","journal-title":"Lab Invest"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-07-1113","volume":"13","author":"Yuan R-H.","year":"2007","unstructured":"Yuan R-H.; Jeng Y-M.; Pan H-W.; Hu F-C.; Lai P-L.; Lee P-H.; Hsu H.C.; Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2007,13(18),5368-5376","journal-title":"Clin Cancer Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.21037\/atm-21-626","volume":"9","author":"Zhang Q.","year":"2021","unstructured":"Zhang Q.; Yuan J.; Liu Y.; Liu X.; Lv T.; Zhou K.; Song Y.; KIAA0101 knockdown inhibits cell proliferation and induces cell cycle arrest and cell apoptosis in chronic lymphocytic leukemia cells. Ann Transl Med 2021,9(6),487","journal-title":"Ann Transl Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.21037\/atm-20-3219","volume":"9","author":"Liu J.","year":"2021","unstructured":"Liu J.; Gao L.; Liao J.; Yang J.; Yuan F.; Chen Q.; Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38\/snail1 pathway in glioma. Ann Transl Med 2021,9(3),260","journal-title":"Ann Transl Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1186\/s12885-020-07463-3","volume":"20","author":"Lei H.","year":"2020","unstructured":"Lei H.; Wang K.; Jiang T.; Lu J.; Dong X.; Wang F.; Li Q.; Zhao L.; KIAA0101 and UbcH10 interact to regulate non-small cell lung cancer cell proliferation by disrupting the function of the spindle assembly checkpoint. BMC Cancer 2020,20(1),957","journal-title":"BMC Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/ijc.31800","volume":"143","author":"Jin C.","year":"2018","unstructured":"Jin C.; Liu Z.; Li Y.; Bu H.; Wang Y.; Xu Y.; Qiu C.; Yan S.; Yuan C.; Li R.; Diao N.; Zhang Z.; Wang X.; Liu L.; Kong B.; PCNA-associated factor P15PAF, targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients. Int J Cancer 2018,143(11),2973-2984","journal-title":"Int J Cancer"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207324666210707105634","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194547\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207324666210707105634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T09:34:26Z","timestamp":1661938466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194547\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207324666210707105634","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-02-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}